Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Many patients with Parkinson's disease (PD) have clinically significant anxiety, depression,
fatigue, sleep disturbance, or sensory symptoms. The comorbidity of these nonmotor …

Objective To determine the estimates of minimal, moderate, and large clinically important
differences (CIDs) for the Unified Parkinson's Disease Rating Scale (UPDRS). Design Cross-…

Objective To compare the efficacy of treadmill exercises and stretching and resistance
exercises in improving gait speed, strength, and fitness for patients with Parkinson disease. …

The objectives of this study are to assess the level of disease severity associated with
disability in Parkinson disease (PD) and the sequence of loss of independence in basic and …

Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

… Shulman, MD … Lisa Shulman earned her BS degree summa cure laude from the State
University of … Shulman joined the faculty at the University of Miami as an assistant professor. Her …

Background: Patient-reported outcomes (PROs) are gaining recognition as key measures
for improving the quality of patient care in clinical care settings. Three factors have made the …

The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline
20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's …

Purpose The Patient-Reported Outcomes Measurement Information System ® (PROMIS ® )
was designed to develop, validate, and standardize item banks to measure key domains of …